Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javid Moslehi

Showing results (61-70 of 148) with videos related to

Pageof 15
Sort By:
Urologic Oncology|September 22, 2020
Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancerAlicia K Morgans, Neal Shore, Diane Cope, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 25, 2023
A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in MelanomaYen-Chou Chen, Muhammad Jaffer, Lylybell Zhou, et al.
Circulation|November 4, 2015
Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer DiagnosisJian Guan, Jay Khambhati, Lee W Jones, et al.
Molecular and Cellular Biology|September 2, 2009
A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivoYoji Andrew Minamishima, Javid Moslehi, Robert F Padera, et al.
Critical Reviews in Oncology/Hematology|August 6, 2025
Cardiovascular safety outcomes of chronic lymphocytic leukemia treatments: A systematic and targeted literature reviewYen-Chou Chen, Paulo Miranda, Yazan K Barqawi, et al.
Circulation|February 3, 2016
Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate CancerNirmanmoh Bhatia, Marilia Santos, Lee W Jones, et al.
JAMA Oncology|September 16, 2016
Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A ReviewWeijuan Li, David Garcia, R Frank Cornell, et al.
Seminars in Oncology|November 23, 2019
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. OncologyEdward T H Yeh, Michael S Ewer, Javid Moslehi, et al.
The Oncologist|March 30, 2026
Cardiac Biomarkers in Patients With Renal Cell Carcinoma Treated With Immune Checkpoint InhibitorsYen-Chou Chen, Mandar A Aras, Brian I Rini, et al.
Haematologica|August 2, 2014
The challenge of cross-trial comparisons using limited dataJacob P Laubach, Edward A Faber, Peter Voorhees, et al.
Pageof 15

Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
Urologic Oncology|September 22, 2020
Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancerAlicia K Morgans, Neal Shore, Diane Cope, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 25, 2023
A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in MelanomaYen-Chou Chen, Muhammad Jaffer, Lylybell Zhou, et al.
Circulation|November 4, 2015
Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer DiagnosisJian Guan, Jay Khambhati, Lee W Jones, et al.
Molecular and Cellular Biology|September 2, 2009
A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivoYoji Andrew Minamishima, Javid Moslehi, Robert F Padera, et al.
Critical Reviews in Oncology/Hematology|August 6, 2025
Cardiovascular safety outcomes of chronic lymphocytic leukemia treatments: A systematic and targeted literature reviewYen-Chou Chen, Paulo Miranda, Yazan K Barqawi, et al.
Circulation|February 3, 2016
Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate CancerNirmanmoh Bhatia, Marilia Santos, Lee W Jones, et al.
JAMA Oncology|September 16, 2016
Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A ReviewWeijuan Li, David Garcia, R Frank Cornell, et al.
Seminars in Oncology|November 23, 2019
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. OncologyEdward T H Yeh, Michael S Ewer, Javid Moslehi, et al.
The Oncologist|March 30, 2026
Cardiac Biomarkers in Patients With Renal Cell Carcinoma Treated With Immune Checkpoint InhibitorsYen-Chou Chen, Mandar A Aras, Brian I Rini, et al.
Haematologica|August 2, 2014
The challenge of cross-trial comparisons using limited dataJacob P Laubach, Edward A Faber, Peter Voorhees, et al.
Pageof 15